5T1K
Cetuximab Fab in complex with CQFDA(Ph)2STRRLKC
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 100 |
Detector technology | IMAGE PLATE |
Collection date | 2011-09-02 |
Detector | RIGAKU RAXIS IV++ |
Wavelength(s) | 1.5418 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 64.280, 83.250, 212.300 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 33.200 - 2.480 |
R-factor | 0.163 |
Rwork | 0.160 |
R-free | 0.21300 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4gw1 |
RMSD bond length | 0.008 |
RMSD bond angle | 1.149 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | MOLREP |
Refinement software | PHENIX (1.8.1_1168) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 33.200 | 2.540 |
High resolution limit [Å] | 2.480 | 2.480 |
Rmerge | 0.053 | 0.248 |
Number of reflections | 41117 | |
<I/σ(I)> | 23.5 | 4.7 |
Completeness [%] | 99.1 | 90.3 |
Redundancy | 4.6 | 3.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 5.5 | 293 | 0.1 CITRIC ACID, 0.1 M SODIUM HYDROGEN PHOSPHATE, 0.5 M POTASSIUM HYDROGEN PHOSPHATE, 1.6 M SODIUM DIHYDROGEN PHOSPHATE, PH 5.5 |